Trega Biosciences, Inc.
Records under this name other than patents Trega Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Trega Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,350,430 | Melanocortin receptor ligands and methods of using same Formerly held Lapsed on the fee record Ended Feb 26, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 26, 2014 | USPTO record |
| US 6,284,735 | HP-3228 and related peptides to treat sexual dysfunction Formerly held Lapsed on the fee record Ended Sep 4, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2013 | USPTO record |
| US 6,262,269 | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries Formerly held Lapsed on the fee record Ended Jul 17, 2013 · USPTO record | Lapsed on the fee record | Ended Jul 17, 2013 | USPTO record |
| US 6,219,537 | Apparatus and method for an enhanced PCS communication system Formerly held Lapsed on the fee record Ended Apr 17, 2013 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2013 | USPTO record |
| US 6,127,381 | Isoquinoline compound melanocortin receptor ligands and methods of using same Formerly held Lapsed on the fee record Ended Oct 3, 2012 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2012 | USPTO record |
| US 6,121,054 | Method for separation of liquid and solid phases for solid phase organic syntheses Formerly held Lapsed on the fee record Ended Sep 19, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 19, 2012 | USPTO record |
| US 6,121,489 | Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein Formerly held Lapsed on the fee record Ended Sep 19, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 19, 2012 | USPTO record |
| US 6,608,082 | Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands Formerly held Lapsed on the fee record Ended Aug 19, 2011 · USPTO record | Lapsed on the fee record | Ended Aug 19, 2011 | USPTO record |
| US 6,534,503 | Melanocortin receptor-3 ligands to treat sexual dysfunction Formerly held Lapsed on the fee record Ended Mar 18, 2011 · USPTO record | Lapsed on the fee record | Ended Mar 18, 2011 | USPTO record |
| US 6,417,195 | Isoquinoline derivatives and isoquinoline combinatorial libraries Formerly held Lapsed on the fee record Ended Jul 9, 2010 · USPTO record | Lapsed on the fee record | Ended Jul 9, 2010 | USPTO record |